Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety: Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02172131
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of BI 1744 CL in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 64
Not applicableActive Not RecruitingNCT07153237
What this trial is testing

Clinical Performance and Safety of STYLAGE® HydroMax

Who this might be right for
AgingAesthetic
Laboratoires Vivacy 81
Early research (Phase 1)Study completedNCT05823870
What this trial is testing

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 32
Early research (Phase 1)Study completedNCT04228302
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Oral EC5026 in Healthy Subjects

Who this might be right for
Healthy Adults
EicOsis Human Health Inc. 40
Very early researchEnded earlyNCT05517837
What this trial is testing

A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants

Who this might be right for
Healthy Participants
Bristol-Myers Squibb 46
Early research (Phase 1)Study completedNCT01288677
What this trial is testing

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Tibotec Pharmaceuticals, Ireland 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06581575
What this trial is testing

Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster (HZ)Infectious DiseasesShingles
Immorna Biotherapeutics, Inc. 467
Early research (Phase 1)Study completedNCT04082754
What this trial is testing

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Who this might be right for
Asthma
CSL Behring 78
Early research (Phase 1)Study completedNCT06641557
What this trial is testing

A Phase I Dosing Study of IkT-148009.

Who this might be right for
Healthy
ABLi Therapeutics, Inc. 6
Early research (Phase 1)Study completedNCT01123772
What this trial is testing

Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers

Who this might be right for
Health
Inotek Pharmaceuticals Corporation 70
Early research (Phase 1)Not Yet RecruitingNCT07516639
What this trial is testing

First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Who this might be right for
Healthy Subjects (HS)SLE (Systemic Lupus)
SUNHO（China）BioPharmaceutical CO., Ltd. 26
Early research (Phase 1)Study completedNCT01231529
What this trial is testing

GSK1349572 Hepatic Impairment Study

Who this might be right for
Healthy SubjectsHepatic ImpairmentInfection, Human Immunodeficiency Virus+1 more
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT00489931
What this trial is testing

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)UnknownNCT03848637
What this trial is testing

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Who this might be right for
Type 2 Diabetes Mellitus
Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT01348737
What this trial is testing

Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

Who this might be right for
Alzheimer's DiseaseSafetyTolerability+2 more
AstraZeneca 72
Early research (Phase 1)Study completedNCT01098877
What this trial is testing

First In Human Study Of Increasing Oral Doses Of PF-04634817

Who this might be right for
Healthy
Pfizer 27
Large-scale testing (Phase 3)Study completedNCT03390166
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Who this might be right for
Influenza
Mahidol University 945
Testing effectiveness (Phase 2)Study completedNCT00309166
What this trial is testing

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 270
Early research (Phase 1)Study completedNCT04916431
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults

Who this might be right for
Healthy Volunteers
ModernaTX, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT03728634
What this trial is testing

Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ).

Who this might be right for
Healthy VolunteershATTR Amyloidosis
Ionis Pharmaceuticals, Inc. 47
Next Page